• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

2017_ABR_Teaser

Download 2017 Valneva Annual Business Report


December 17, 2018
Valneva Initiates Phase 2 Clinical Development for its Lyme Disease Vaccine Candidate

Read more

— Stock information

@valnevase




-
— November 19, 2018
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for their Vaccine Candidate Against the Zika Virus

Read more
— Financial Calendar

February 21, 2019
Revenues 2018

March 21, 2019
2018 Financial Statements

See all dates

AKTUELLES

News in German


 
VALNEVA
LIBRARY


Images, presentations and videos

JAPANESE
ENCEPHALITIS
AND
CHOLERA



learn more
play video Company Video

– Upcoming conferences



January 7-10, 2019
Investor meetings during Annual JP Morgan healthcare conference, San Francisco

April 15-17, 2019
World Vaccine Congress, Washington D.C.
 
Please update your browser...